Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Opinion in Biotechnology
|
February 5, 2003
Chemical proteomics and its application to drug discovery
Douglas A Jeffery, Matthew Bogyo
Drug Discovery Today
|
April 12, 2013
Chemical proteomics and its application to drug discovery
Douglas A Jeffery, Matthew Bogyo
Trends in Cell Biology
|
January 20, 2004
Enzyme activity--it's all about image
Amos Baruch, Douglas A Jeffery, Matthew Bogyo
Journal of Proteome Research
|
January 12, 2008
"Product ion monitoring" assay for prostate-specific antigen in serum using a linear ion-trap
Vathany Kulasingam, Christopher R Smith, Ihor Batruch, et al.
Current Protocols in Protein Science
|
April 23, 2008
Applications for chemical probes of proteolytic activity
Matthew Bogyo, Amos Baruch, Douglas A Jeffery, et al.
Clinical Chemistry
|
November 11, 2015
US Food and Drug Administration Perspectives on Clinical Mass Spectrometry
Julia Tait Lathrop, Douglas A Jeffery, Yvonne R Shea, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2005
3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity
Eduardo L Setti, Dana Davis, James W Janc, et al.
Journal of Proteome Research
|
July 8, 2015
Quantitative Proteomic Verification of Membrane Proteins as Potential Therapeutic Targets Located in the 11q13 Amplicon in Cancers
Heather Hoover, Jun Li, Jason Marchese, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 24, 2006
Development of activity-based probes for trypsin-family serine proteases
Zhengying Pan, Douglas A Jeffery, Kareem Chehade, et al.
Chemmedchem
|
December 13, 2006
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase
Zhengying Pan, Heleen Scheerens, Shyr-Jiann Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Opinion in Biotechnology
|
February 5, 2003
Chemical proteomics and its application to drug discovery
Douglas A Jeffery, Matthew Bogyo
Drug Discovery Today
|
April 12, 2013
Chemical proteomics and its application to drug discovery
Douglas A Jeffery, Matthew Bogyo
Trends in Cell Biology
|
January 20, 2004
Enzyme activity--it's all about image
Amos Baruch, Douglas A Jeffery, Matthew Bogyo
Journal of Proteome Research
|
January 12, 2008
"Product ion monitoring" assay for prostate-specific antigen in serum using a linear ion-trap
Vathany Kulasingam, Christopher R Smith, Ihor Batruch, et al.
Current Protocols in Protein Science
|
April 23, 2008
Applications for chemical probes of proteolytic activity
Matthew Bogyo, Amos Baruch, Douglas A Jeffery, et al.
Clinical Chemistry
|
November 11, 2015
US Food and Drug Administration Perspectives on Clinical Mass Spectrometry
Julia Tait Lathrop, Douglas A Jeffery, Yvonne R Shea, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2005
3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity
Eduardo L Setti, Dana Davis, James W Janc, et al.
Journal of Proteome Research
|
July 8, 2015
Quantitative Proteomic Verification of Membrane Proteins as Potential Therapeutic Targets Located in the 11q13 Amplicon in Cancers
Heather Hoover, Jun Li, Jason Marchese, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 24, 2006
Development of activity-based probes for trypsin-family serine proteases
Zhengying Pan, Douglas A Jeffery, Kareem Chehade, et al.
Chemmedchem
|
December 13, 2006
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase
Zhengying Pan, Heleen Scheerens, Shyr-Jiann Li, et al.
Page
of 2